Assembly Biosciences, Inc. (ASMB) Social Stream
ASSEMBLY BIOSCIENCES INC (ASMB) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ASSEMBLY BIOSCIENCES INC.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
ASMB's average price target has moved down $37.33 over the prior 27 months.
Over the past 40 weeks, ASMB's average upside potential has been 239.84%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ASMB Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 153 days, ASMB's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- ASSEMBLY BIOSCIENCES INC's variance in analysts' estimates is lower than -765.83% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, ASSEMBLY BIOSCIENCES INC's average analyst price target is greater than 59.75% of them.
- ASMB has a greater number of analysts covering the stock than 156.56% of Healthcare stocks.
- In terms of how ASSEMBLY BIOSCIENCES INC fares relative to stocks in the small market cap category, note that its upside potential (average analyst target price relative to current price) is higher than 643.24% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ASSEMBLY BIOSCIENCES INC are ARQT, ARDX, and ARCT.
What is the outlook for ASMB? Use POWR Ratings for clearer insight into price direction.